Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment

Biological Psychiatry

Volumn 62, Issue 5, 2007, Pages 407-414

  Chen, Chi Hua ^a   Ridler, Khanum ^a,b   Suckling, John ^a   Williams, Steve ^c   Fu, Cynthia H Y ^c   Merlo Pich, Emilio ^d   Bullmore, Ed ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GSK   (Italy)

Author keywords

Anterior cingulate cortex; antidepressant; Depression; magnetic resonance imaging; neuroimaging; treatment response

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; ARTICLE; BRAIN; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HAMILTON SCALE; HUMAN; INSULA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SYMPTOM; TEMPORAL CORTEX;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN MAPPING; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34249810970     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.09.018     Document Type: Article

References (46)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Barbas H., Saha S., Rempel-Clower N., and Ghashghaei T. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci 4 (2003) 25
3. Berton O., and Nestler E.J. New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci 7 (2006) 137-151
4. Brammer M.J., Bullmore E.T., Simmons A., Williams S.C., Grasby P.M., Howard R.J., et al. Generic brain activation mapping in functional magnetic resonance imaging: A nonparametric approach. Magn Reson Imaging 15 (1997) 763-770
5. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54 (1997) 364-374
6. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 91 (1999) 127-139
7. Brody T.M., Larner J., and Minneman K.P. Human Pharmacology: Molecular to Clinical. 3rd ed. (1998) St. Louis. Missouri. Mosby-Year Book
8. Bullmore E.T., Brammer M.J., Rabe-Hesketh S., Curtis V.A., Morris R.G., Williams S.C., et al. Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp 7 (1999) 38-48
9. Bullmore E.T., Suckling J., Overmeyer S., Rabe-Hesketh S., Taylor E., and Brammer M.J. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18 (1999) 32-42
10. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4 (2000) 215-222
11. Castrogiovanni P., Blardi P., de Lalla A., Dell'Erba A., and Auteri A. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?. Psychopharmacol Bull 37 (2003) 102-108
12. Davidson R.J., Abercrombie H., Nitschke J.B., and Putnam K. Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol 9 (1999) 228-234
13. Davidson R.J., Irwin W., Anderle M.J., and Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160 (2003) 64-75
14. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 985 (2003) 420-444
15. Ekman P., and Friesen W.V. Pictures of Facial Affect (1976), Consulting Psychologists Press, Palo Alto, California
16. Figueras G., Perez V., San Martino O., Alvarez E., and Artigas F. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos. Biol Psychiatry 46 (1999) 518-524
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders (1995), American Psychiatric Press, New York
18. Freedman L.J., Insel T.R., and Smith Y. Subcortical projections of area 25 (subgenual cortex) of the macaque monkey. J Comp Neurol 421 (2000) 172-188
19. Fu C.H.Y., Williams S.C.R., Cleare A.J., Brammer M.J., Walsh N.D., Kim J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61 (2004) 877-889
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
21. Hardy S.G., and Leichnetz G.R. Cortical projections to the periaqueductal gray in the monkey: A retrograde and orthograde horseradish peroxidase study. Neurosci Lett 22 (1981) 97-101
22. Holsboer F. Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST. Pharmacopsychiatria 16 (1983) 186-191
23. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1085-1093
24. Jenkinson M., Bannister P., Brady M., and Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 (2002) 825-841
25. Jenkinson M., and Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 5 (2001) 143-156
26. Kalayam B., and Alexopoulos G.S. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 56 (1999) 713-718
27. Kimbrell T.A., Ketter T.A., George M.S., Little J.T., Benson B.E., Willis M.W., et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51 (2002) 237-252
28. Kugaya A., Sanacora G., Staley J.K., Malison R.T., Bozkurt A., Khan S., et al. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biol Psychiatry 56 (2004) 497-502
29. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8 (1997) 1057-1061
30. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
31. Muller-Preuss P., and Jurgens U. Projections from the 'cingular' vocalization area in the squirrel monkey. Brain Res 103 (1976) 29-43
32. Phillips M.L., Drevets W.C., Rauch S.L., and Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54 (2003) 515-528
33. Pizzagalli D., Pascual-Marqui R.D., Nitschke J.B., Oakes T.R., Larson C.L., Abercrombie H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. Am J Psychiatry 158 (2001) 405-415
34. Saxena S., Brody A.L., Ho M.L., Zohrabi N., Maidment K.M., and Baxter Jr. L.R. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 160 (2003) 522-532
35. Schutter D.J., and van Honk J. A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression. J Psychiatry Neurosci 30 (2005) 91-97
36. Seminowicz D.A., Mayberg H.S., McIntosh A.R., Goldapple K., Kennedy S., Segal Z., et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 22 (2004) 409-418
37. Serretti A., Benedetti F., Zanardi R., and Smeraldi E. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1074-1084
38. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J., and Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3 (1998) 508-511
39. Smith S.M. Fast robust automated brain extraction. Hum Brain Mapp 17 (2002) 143-155
40. Suckling J., and Bullmore E. Permutation tests for factorially designed neuroimaging experiments. Hum Brain Mapp 22 (2004) 193-205
41. Surguladze S., Brammer M.J., Keedwell P., Giampietro V., Young A.W., Travis M.J., et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57 (2005) 201-209
42. Talairach J., and Tournoux P. A Coplanar Stereotactic Atlas of the Human Brain (1988), Georg Thieme Verlag, Stuttgart, Germany
43. Varnas K., Halldin C., and Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22 (2004) 246-260
44. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 6 (2005) 533-544
45. Vogt B.A., and Pandya D.N. Cingulate cortex of the rhesus monkey: II. Cortical afferents. J Comp Neurol 262 (1987) 271-289
46. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20 (2001) 45-57